An interdisciplinary research team has unveiled the world's first artificial intelligence (AI) model designed to classify both the cancer stage and risk category of thyroid cancer, achieving impressive accuracy exceeding 90%. This innovative AI model promises to significantly cut frontline clinicians' pre-consultation preparation time by approximately 50%, aligning with the HKSAR Government's initiative to harness AI technology in healthcare.
Read more …AI model for thyroid cancer diagnosis, with over 90% accuracy and reduced consultation preparation...
In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as skin, lung, or bone and soft tissue cancer (sarcomas), they have not yet proven themselves as a treatment method. Tumor shrinkage was achieved only in rare cases, but the side effects were all the more severe. An international research group led by scientists has now succeeded in a phase 1 clinical trial in testing a novel cell therapy approach that also shows promise for solid tumors.
Read more …New cell therapy shows promising results in advanced tumor diseases
People with the hereditary disease familial adenomatous polyposis (FAP) have a greatly increased risk of developing a malignant tumor of the duodenum. Researchers have now discovered a mechanism in the local immune system that can drive the development of cancer. They see this as a promising new approach to preventing duodenal carcinoma in people with FAP.
Read more …New way to prevent duodenal cancer